Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848497 · ClinicalTrials.gov registry record · Early Phase 1
Testosterone for Penile Rehabilitation After Radical Prostatectomy
A Early Phase 1 study, sponsored by Mohit Khera.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00848497: Clinical Trial Early Phase 1 study, sponsored by Mohit Khera.
NCT00848497 is a Early Phase 1 study that was terminated before completion, run by Mohit Khera. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00848497, a Early Phase 1 study, was terminated before completion, sponsored by Mohit Khera.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone gel) 5 g per day plus Viagra 25 mg every night and the other will receive Placebo-Testim® 5 g per day plus Viagra 25 mg every night. Subjects will begin drug treatment 3 months after the initial screening visit and will take study drug for 3 months only. Participation will end at the end of the 6-month visit.
Primary Outcome
SHIM range is 0-25. 0= no sexual activity;1-7 severe ED; 8-11 Moderate ED; 12-16 Mild to Moderate ED; 17-21 Mild ED
Interventions
- DRUG Testim®
- OTHER Placebo Testim®
- DRUG Viagra®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Why NCT00848497 stopped before completion
NCT00848497 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Testim® is the first listed.
NCT00848497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00848497 about?
NCT00848497 is a clinical study titled "Testosterone for Penile Rehabilitation After Radical Prostatectomy". The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone ...
What is the current status of trial NCT00848497?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2007-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00848497?
The interventions under investigation include: Testim® (DRUG), Placebo Testim® (OTHER), Viagra® (DRUG).
Who is sponsoring clinical trial NCT00848497?
This trial is sponsored by Mohit Khera, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00848497's enrollment target sits among peer trials
3 1948th of 2000 higher than 28 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia